TAPBP and neoplasm: Our results showed that TAPBP promoter hypermethylation in the PPAT of obese PCa subjects likely reduced the expression or activity of TAPBP, downregulating tumor cell’s antigen presentation of immune cells in PPAT, leading to impaired CD8+ T cell activation (Fig. 4).